Ruggedness of Visible Residue Limits for Cleaning Validation - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Ruggedness of Visible Residue Limits for Cleaning Validation
The author tests the ruggedness of VRL viewing conditions and defines optimal viewing conditions.

Pharmaceutical Technology
Volume 33, Issue 3, pp. 102-111

Methods and materials

As the VRL program expanded at the author's single site, a larger pool of observers came in. The expanded pool of observers included 20–30 scientists. In addition, equipment washers and supervisory personnel were trained in VRLs and visual inspection of clean equipment. Data from the additional VRLs were compared with the original work. The data set was also analyzed for API, excipient, and formulation correlations.

The multisite study consisted of the company's three international sites: West Point in the United States, Montréal in Canada, and Hoddesdon in England. Each site determined VRL for the same five APIs. Visual determinations were based on two grades of stainless-steel coupons from a common source: milled or 316-finish stainless steel (the grade of material on most manufacturing equipment) and mirror-finish stainless steel. The experimental conditions, as defined previously, were the same as those used for the pilot plant: a distance of 18 in., a viewing angle of 30°, and a light intensity level of >200 lux.

Personnel at each site weighed approximately 20 mg of the respective test material and placed it into a 25-mL volumetric flask. They dispersed the material using a newly opened bottle of high-performance liquid chromatography (HPLC) grade methanol, added the methanol to completely dissolve or disperse the material, and brought the flask to volume. The resulting sample concentration was approximately 800 μg/mL.

Table I: Residue target concentrations.
After verifying that the coupons were visually clean before use, personnel cleaned the coupons with methylene chloride, chloroform, or methanol to remove any residue from the coupon that might interfere with the residue-spotting process or visual observations. Spot residues were prepared according to conditions listed in Table I. The range of spots was targeted to span between ARL at 4 μg/cm2 to below VRL and intended to cover approximately 25 cm2. The target spot size was a 5-cm diameter circle, or 20 cm2. The consistency of spotting areas was important to the eventual spot concentration and, therefore, personell made every attempt to keep residue spots consistently close to the intended size. Residues were arranged in order of descending concentration for consistency among sites and spotted by pipetting 100 μL of the appropriate sample onto the stainless-steel coupon. The residue was then dried and the area of each residue spot was determined.

If prepared correctly, each of the residue spots generally approximated a circle. The area was calculated by measuring the circle's diameter. If the spot resembled more of an oval, two diameter measurements provided the area. The amount of residue was divided by the spot area to find the concentration of residue.

The coupons were placed on a flat background and the ambient light level was measured to verify accuracy. The identity and concentration of each spot was unknown to the observers. The coupons were oriented so that each spot could be observed from the same distance and angle, and the ability of each observer to see each of the residue spots was recorded.

The highest standard spot for APIs was 100 μL of an 800-μg/mL solution or suspension in methanol. This resulted in a circular residue with an approximate diameter of 5 cm, which was approximately the size of the swab area (25 cm2). Various decreasing concentrations with the same volume resulted in VRL when the residue was no longer visible to all observers. If the lowest spotted residue was visible to the observers, then the VRL was reported as "less than" the lowest spotted residue concentration. For VRLs with the "less than" designation, the lowest tested residue was sufficiently lower than the ARL as to not pose a significant risk of cleaning failure.

To address the phenomenon of residue appearance, various volumes of the same concentration solution near to VRL were spotted to complement existing data and to determine if there was an effect on the appearance of residue and subsequent VRL determination.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here